The purpose of this study is to investigate the applicability and feasibility of the newly developed robot platform for upper extremity therapy ("ChARMin") in children undergoing neurorehabilitation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
ChARMin-1: Score on the feasibility questionnaire [points]
Timeframe: Up to 8 weeks
ChARMin-2: Game Scores [points]
Timeframe: up to 24 weeks
ChARMin-3: Assessment battery integrated into the ChARMin software [points]
Timeframe: Up to 24 weeks
ChARMin-3: Change from baseline of the assessment battery integrated into the ChARMin software [delta points]
Timeframe: Twice within 3-7 days
ChARMin-3: Change from baseline of the assessment battery integrated into the ChARMin software
Timeframe: At onset and end of the hospital stay, which covers an expected average of 7 weeks
ChARMin-4 and ChARMin-6: Change from baseline in the Box and Block Test [delta of the number of blocks transferred]
Timeframe: At onset and end of hospital stay, which covers an expected average of 7 weeks
ChARMin-5: Game scores [points]
Timeframe: up to 24 weeks